Technology Press Releases
SEE OTHER BRANDS

Get your fresh news on technology in the world

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on August 10, 2025

Managing Domains with Hosted.com Control Panel’s Enhanced Tools and Features

Managing Domains with Hosted.com Control Panel’s Enhanced Tools and Features

Manage domains, emails, DNS, subdomains …

VAP Group with Abu Dhabi Convention & Exhibition Bureau, is set to host all AI futurists at The Global AI Show

VAP Group with Abu Dhabi Convention & Exhibition Bureau, is set to host all AI futurists at The Global AI Show

ABU DHABI, UNITED ARAB EMIRATES, August 11, 2025 /⁨EINPresswire.com⁩/ -- Following the resounding success of past two editions, VAP Group in association with and Times of AI and supported by Abu Dhabi Convention …

Strategic Partnership Between ZagTrader and Karmal Brokerage to Enhance Trading Capabilities in Iraq

Strategic Partnership Between ZagTrader and Karmal Brokerage to Enhance Trading Capabilities in Iraq

DUBAI, UNITED ARAB EMIRATES, August 10, 2025 /⁨EINPresswire.com⁩/ -- ZagTrader, a leading global provider of trading and investment technology solutions, has announced a strategic partnership with Karmal Brokerage, a prominent Iraqi brokerage firm. This …

GVNR: Unlocking Permissionless, Peer-to-Peer Asset Control Across All Chains

GVNR: Unlocking Permissionless, Peer-to-Peer Asset Control Across All Chains

Singapore, Aug. 10, 2025 (GLOBE NEWSWIRE) -- Cross-chain infrastructure has long been burdened by bridge-related vulnerabilities, centralization risks, and fragmented liquidity. GVNR introduces a new paradigm — permissionless, peer-to-peer control of …

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company, today announced the company will hold a conference call and webcast on Monday, August 11, 2025, at 8:30 AM ET to disclose the topline results …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions